Curated GI articles August 19th, 2022: GI Alliance valued at $2.2 bln in Apollo-backed deal

Curated GI articles August 19th, 2022: GI Alliance valued at $2.2 bln in Apollo-backed deal

Curated GI articles August 19th, 2022:
GI Alliance valued at $2.2 bln in Apollo-backed deal
Industry Payments Among GI Docs Fell After Open Payments: Study (Medscape)
Industry payments to U.S. gastroenterologists and hepatologists increased from 2014 to 2016 before beginning to steadily decrease after 2016, according to new research.
GI Alliance valued at $2.2 bln in Apollo-backed deal (Reuters)
Apollo Global Management Inc (APO.N) said on Friday it had invested $785 million in GI Alliance, as part of a deal that values the gastroenterology-care platform at $2.2 billion.
30 stats on the gastroenterology industry (Becker’s GI & Endoscopy)
The gastroenterology industry is constantly evolving — here’s where it stands today through the lenses of salary, ASC case mix, procedure costs and other statistics.
VIDEO: Consolidation ‘not just about getting bigger — it’s about getting better’ (Healio)
In a Healio exclusive, Jim Leavitt, MD, FASGE, director of clinical quality and outcomes at Gastro Health in Miami, discusses the trends, benefits and risks of consolidation in GI practice.
Should You Sell Your Practice to a Private Equity Firm? (Medscape)
While the potential profit may seem alluring, physicians have mixed feelings as to whether this will be a boon or a disappointment.
How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice (JNM)
This review aims to discuss ways to optimally use the FODMAP diet in practice in a wide range of cultures, directed at gastroenterologists from a dietitian’s perspective.
Erica Barnell, Ph.D. and Aasma Shaukat, MD on Geneoscopy, RNA-based stool testing, and CRC screening (GI StartUp Podcast)
A discussion with Aasma Shaukat, MD, MPH and Erica Barnell, PhD on RNA-based stool testing, how Geneoscopy is thinking about patient recruitment for trials, the future of CRC screening, and more.
Strengths and weaknesses of an AI polyp detection program (AGA)
A high-detecting endoscopist tests and assesses the first FDA-approved CADe program.
‘Every one of us should be thinking about succession planning,’ GI expert says (Healio)
“Succession planning is simply a strategy or process for identifying and developing future leaders,” Joseph J. Vicari, MD, MBA, FASGE, a gastroenterologist at Rockford Gastroenterology Associates.
Risk-Adapted Screening for CRC Comparable to Established Strategies (Medpage Today)
A personalized risk-adapted screening approach that prioritizes colonoscopy for those at high risk for colorectal cancer (CRC) was effective and affordable, a randomized trial has shown.
EndoQuest Robotics Endoluminal Surgical (ELS) System Wins 2022 Surgical Robotic Challenge (PR Newswire)
ENDOQUEST Robotics, enables therapeutic endoscopists and surgeons scar-free and less invasive surgical procedures.
Gastroenterology Consultants PA (GCPA) data breach class action settlement (Top Class Actions)
Houston-based Gastroenterology Consultants PA has agreed to settle consumer claims that the practice failed to protect consumers from a data breach last year.
Pancreatic cancer screening in new-onset diabetes appears cost effective (MDedge)
A risk-tailored early-detection strategy for pancreatic cancer that targets patients with new-onset diabetes could be cost effective, according to a recent study.
AI Appears Destined to Be Standard In Barrett’s Esophagus Surveillance (GI & Endoscopy News)
Compared with expert endoscopists, AI was found to be more than twice as accurate and sensitive in a data pool that evaluated the use of different AI strategies and methodologies.
Will Medicare Physician Fee Schedule Changes Drive Value-Based Care? (RevCycle Intelligence)
The proposed changes in the Medicare Physician Fee Schedule (PFS) for calendar year (CY) 2023 may offer incentives for provider groups to consider alternative payment models.
Evoke Pharma and EVERSANA Expand Patient Access to GIMOTI® With New Telehealth Solution (Evoke Pharma)
Patients with symptoms of Diabetic Gastroparesis now have direct-to-patient treatment support powered by UpScriptHealth.
An endoscopy is worth more than a thousand labs (AJG)
The August Issue features a new ACG Clinical Guideline on Gastroparesis, the need of ending disparities in liver transplantation. Know why an endoscopy is worth a thousand labs and more.
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) (Nature)
The review discusses recent developments in prospective therapeutic targets, as well as pharmacological candidates in pre/clinical trials, with a focus on diabetes, hepatic lipid metabolism, inflammation, and fibrosis.

More Hot headlines in GI

ICYMI- Scope Forward Show: Greg O’Grady, CEO Of Alimetry: “As Clinicians, Some Of Our Skills May Become Relatively Obsolete” (NextServices)

4th Global Gastroenterology & Artificial Intelligence Summit (ASGE)

Mayo Clinic researchers study rare genetic condition to tackle colorectal cancer (EurekAlert)

Gastric Bypass Linked to Younger Onset of Severe Alcoholic Hepatitis (GI & Endoscopy News)

Goldberg and Sussman Dissect Disparities in Gastric Cancer Mortality Rates (OncLive)

ImmunogenX and Mayo Clinic Celiac Disease Study Published in Gastroenterology (Business Wire)

New Method Detects Gut Microbes That Activate Immune Cells (Newswise)

Duodenoscopes: Throw Them Out? Or Put Them in the Wash? (GI & Endoscopy News)

Global Prevalence of Nonalcoholic Fatty Liver Disease on the Rise (Gastroenterology Advisor)

Liver Disease Expert Dr. Raza Malik Joins Albany Medical Center as Chief of the Division of Gastroenterology and Hepatology (Albany Med)

Videos: Interviews with GI Leaders  (NextServices)

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.

Write a Comment